TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,040,767 | +13.7% | 67,276 | +17.3% | 0.08% | +17.9% |
| Q2 2023 | $915,038 | +26.9% | 57,370 | +31.1% | 0.07% | +19.6% |
| Q1 2023 | $721,005 | +35.4% | 43,750 | +28.1% | 0.06% | +12.0% |
| Q4 2022 | $532,605 | +101.7% | 34,141 | +85.0% | 0.05% | +100.0% |
| Q1 2022 | $264,000 | +26.9% | 18,453 | +21.1% | 0.02% | +47.1% |
| Q4 2021 | $208,000 | +7.2% | 15,237 | +28.7% | 0.02% | 0.0% |
| Q3 2021 | $194,000 | -36.2% | 11,840 | -28.9% | 0.02% | -48.5% |
| Q1 2021 | $304,000 | +56.7% | 16,656 | +53.0% | 0.03% | +22.2% |
| Q3 2020 | $194,000 | +2.1% | 10,887 | +4.5% | 0.03% | -6.9% |
| Q2 2020 | $190,000 | – | 10,418 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |